STAT+: Disagreements and digs upend an otherwise bipartisan hearing on PBM reform

A Senate health committee markup on PBM reform was rocky from the start — and downhill from there.

WASHINGTON — The first Senate health committee markup under Chair Bernie Sanders (I-Vt.) and ranking Republican Bill Cassidy (La.) was rocky from the start — and it only went downhill from there.

The committee was supposed to consider several bills to reform drug middlemen practices and make changes to laws governing generic drugs. But the markup was marred by procedural disagreements and ultimately adjourned unexpectedly, over Sanders’ efforts to continue.

Continue to STAT+ to read the full story…